Latticework Capital Forms ACRS Platform and Acquires Catalina Research Institute
September 13, 2022
Dallas-based private equity firm Latticework Capital Management formed American Clinical Research Services Holdings (ACRS) and, through the new platform, acquired Montclair, California–based Catalina Research Institute, LLC (CRI). The deal establishes an SMO platform focused on complex clinical trials and patient diversity to scale site operations, improve trial efficiencies and expand CRI's reach; financial terms were not disclosed.
- Buyers
- Latticework Capital Management, American Clinical Research Services Holdings
- Targets
- Catalina Research Institute, LLC
- Platforms
- American Clinical Research Services Holdings
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
American Clinical Research Services Acquires Elixia
May 8, 2024
Healthcare Services
American Clinical Research Services (ACRS), a clinical research platform formed by Latticework Capital Management, has acquired Elixia, a multi-specialty clinical research site network operating in Florida, Massachusetts, Michigan and Missouri. The acquisition expands ACRS's footprint and capabilities in complex therapeutic areas—notably nephrology, neuroscience and infectious diseases—and adds Elixia's 40-bed Phase I unit in Tampa to ACRS's national site network.
-
American Clinical Research Services (ACRS) Acquires Clinical Site Services (CSSi) and Patient Advertising Guru (PAG)
May 9, 2023
Healthcare Services
ACRS, a site management organization platform backed by Latticework Capital Management, has acquired Clinical Site Services (CSSi) and Patient Advertising Guru (PAG). The add-on deals expand ACRS's patient recruitment, media/advertising and local enrollment capabilities to support clinical trial enrollment across multiple therapeutic areas and geographies.
-
Catalyst Clinical Research Acquires Aptus Clinical
May 4, 2022
Healthcare Services
Catalyst Clinical Research, a portfolio company of NovaQuest Capital Management, has acquired U.K.-based Aptus Clinical to accelerate Catalyst's European expansion and broaden its oncology and early-phase clinical services. The deal creates a multi-region CRO operating across North America and Europe, increases Catalyst's patient reach by nearly 600 and lifts combined headcount to more than 800.
-
Carisk Partners Acquires Advanced Claims Review Specialists (ACRS)
December 13, 2022
Healthcare Services
Carisk Partners, an MBF Healthcare Partners II portfolio company, has completed the acquisition of Advanced Claims Review Specialists (ACRS), a medical cost containment firm that performs evidence-based analysis of medical bills and records. The deal expands Carisk's capabilities in hospital and medical fee negotiation and enhances its ability to manage billed charges in catastrophic workers' compensation cases.
-
Headlands Research Acquires AMCR Institute
July 27, 2023
Healthcare Services
Headlands Research has acquired AMCR Institute, a San Diego–based clinical research site specializing in metabolic, endocrine and medical device research (including continuous glucose monitors). The site will operate as Headlands Research AMCR Institute as part of Headlands' expanding network of clinical trial sites to support more trials and broaden therapeutic and device capabilities.
-
Alcanza Clinical Research Acquires Kansas City Research Institute
May 1, 2024
Healthcare Services
Alcanza Clinical Research, an integrated investigator site network, has acquired Kansas City Research Institute (KCRI), a Phase II–IV clinical research site based in Kansas City, Missouri. The acquisition expands Alcanza's Midwest footprint and therapeutic capabilities in gastroenterology, hepatology and metabolic diseases while increasing trial access for underrepresented patient populations.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.